Figure (Pro0n 0005 01)
Propofol Injection, Emulsion
Product Images NDC 25021-608
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Propofol (NDC 25021-608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Pro0n 0005 02)
This is a graph that shows the relationship between plasma propofol concentration (meg/mL) and the recovery time after different durations of infusion (10-day, 10-hour, and 1-hour). The x-axis shows the minutes after the end of infusion, while the y-axis shows the plasma concentration of propofol. The target plasma concentration is 1.00 meg/mL, and the recovery time from anesthesia is shown in the graph.*
Package Label – Principal Display Panel – Vial Label (Pro0n 0005 03)
This appears to be the label of an injectable emulsion drug manufactured in Italy by Sagent Pharmaceuticals, Inc. Unfortunately, there is no name of the drug or indication of its use available on the label.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
